TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019)
TELA Bio (TELA) posted quarterly Preferred Stock Liabilities of $1.6 million for Q3 2019, down 94.97% year-over-year from $32.7 million in Q3 2018, and down 95.17% quarter-over-quarter from $34.0 million in Q2 2019.
TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends
TELA Bio's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $1.6 million for Q3 2019.
- In Q3 2019, Preferred Stock Liabilities fell 94.97% year-over-year to $1.6 million; the TTM figure through Sep 2019 stood at $1.6 million (down 94.97% YoY), while the FY2018 annual figure was $1.6 million, down 97.96% from the prior year.
- Preferred Stock Liabilities for Q3 2019 stood at $1.6 million, down from $34.0 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $34.0 million in Q2 2019, with the low at $1.6 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.64 Mn |
| Jun 30, 2019 | 34.01 Mn |
| Dec 31, 2018 | 1.64 Mn |
| Sep 30, 2018 | 32.66 Mn |